Point72 Asset Management’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29M Sell
2,722,754
-2,649,250
-49% -$26.8M 0.05% 625
2025
Q4
$50.4M Buy
5,372,004
+2,031,452
+61% +$15.9M 0.08% 403
2025
Q3
$25.2M Buy
3,340,552
+1,533,334
+85% +$7.68M 0.05% 474
2025
Q2
$6.09M Sell
1,807,218
-10,640
-0.6% -$39.8K 0.01% 902
2025
Q1
$7.02M Sell
1,817,858
-38,892
-2% -$186K 0.02% 811
2024
Q4
$11.5M Buy
1,856,750
+256,010
+16% +$1.48M 0.03% 643
2024
Q3
$8.61M Buy
1,600,740
+609,939
+62% +$2.87M 0.03% 691
2024
Q2
$3.32M Buy
990,801
+397,285
+67% +$1.55M 0.01% 960
2024
Q1
$2.39M Buy
+593,516
New +$1.59M 0.01% 1203
2023
Q4
Sell
-1
Closed -$2 2335
2023
Q3
$2 Sell
1
-5,348
-100% -$24.9K ﹤0.01% 2403
2023
Q2
$33.7K Sell
5,349
-4,781
-47% -$29.3K ﹤0.01% 1694
2023
Q1
$58.5K Buy
+10,130
New +$75.8K ﹤0.01% 1753

Other funds holding DSGN